Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter

Safe access to the most effective treatment options for  Plasmodium vivax malaria are limited by the absence of accurate point-of-care testing to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common human genetic disorder. G6PD-deficient patients are at risk of life-threatenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Cindy S, Bancone, Germana, Kelley, Maureen, Advani, Nicole, Domingo, Gonzalo J, Cutiongo-de la Paz, Eva M, van der Merwe, Nicole, Cohen, Jessica, Gerth-Guyette, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388194/
https://www.ncbi.nlm.nih.gov/pubmed/32766454
http://dx.doi.org/10.12688/wellcomeopenres.15700.2